Biechele Royce Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$225K Sell
1,391
-2
-0.1% -$319 0.07% 53
2024
Q2
$204K Sell
1,393
-34
-2% -$5.06K 0.07% 57
2024
Q1
$226K Sell
1,427
-28
-2% -$4.46K 0.07% 54
2023
Q4
$228K Sell
1,455
-88
-6% -$13.5K 0.07% 59
2023
Q3
$240K Buy
1,543
+27
+2% +$4.46K 0.09% 60
2023
Q2
$251K Sell
1,516
-1,326
-47% -$214K 0.09% 60
2023
Q1
$440K Sell
2,842
-1,247
-30% -$201K 0.16% 46
2022
Q4
$722K Hold
4,089
0.29% 38
2022
Q3
$668K Sell
4,089
-1,347
-25% -$228K 0.31% 37
2022
Q2
$964K Buy
5,436
+4,032
+287% +$718K 0.43% 35
2022
Q1
$248K Hold
1,404
0.1% 53
2021
Q4
$240K Buy
1,404
+1
+0.1% +$164 0.1% 57
2021
Q3
$227K Buy
+1,403
New +$239K 0.1% 56
2019
Q1
Sell
-1,914
Closed -$247K 48
2018
Q4
$247K Sell
1,914
-803
-30% -$112K 0.18% 44
2018
Q3
$375K Sell
2,717
-74
-3% -$9.83K 0.23% 42
2018
Q2
$339K Buy
2,791
+54
+2% +$6.74K 0.23% 44
2018
Q1
$351K Buy
2,737
+73
+3% +$9.87K 0.25% 44
2017
Q4
$372K Buy
+2,664
New +$371K 0.25% 44

Other funds holding JNJ

Biechele Royce Advisors's JNJ Position: Q3 2024 in Review

Biechele Royce Advisors reduced its Johnson & Johnson (JNJ) stake by 0.14% in Q3 2024, selling an estimated $319 and leaving 1,391 shares worth $225K. The position accounts for 0.07% of the portfolio, ranked #53.

Biechele Royce Advisors first reported a position in JNJ in Q4 2017 and has held it in 18 quarters since. The position peaked at $964K in Q2 2022. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Biechele Royce Advisors held 1,391 shares of Johnson & Johnson worth $225K as of Q3 2024.
  • Biechele Royce Advisors sold 2 Johnson & Johnson shares in Q3 2024, an estimated $319.
  • Johnson & Johnson made up 0.07% of Biechele Royce Advisors's portfolio in Q3 2024, its #53 holding.
  • Biechele Royce Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 18 quarters since.
  • Biechele Royce Advisors's Johnson & Johnson position peaked at $964K in Q2 2022.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Biechele Royce Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.